Clinical Trials Browser

Pancreatic Adenocarcinoma × Nivolumab × Gastrointestinal × Clear all

NCT03404960 2025-10-10

Parpvax

Phase 1/2 Completed

104 enrolled 11 charts

Gastrointestinal

Pancreatic Adenocarcinoma